Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Molecular Pharmaceutics|July 20, 2005
Regional intestinal absorption and biliary excretion of fluvastatin in the rat: possible involvement of mrp2Anders Lindahl, Asa Sjöberg, Ulf Bredberg, et al.Pharmaceutical Research|February 9, 2010
Hepatic disposition of ximelagatran and its metabolites in pig; prediction of the impact of membrane transporters through a simple disposition modelErik Sjögren, Ulf Bredberg, Erik Allard, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 15, 2010
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methodsMarkus Fridén, Fredrik Bergström, Hong Wan, et al.European Journal of Clinical Pharmacology|May 14, 2003
Pharmacokinetics and pharmacodynamics of ximelagatran, a novel oral direct thrombin inhibitor, in young healthy male subjectsUlf G Eriksson, Ulf Bredberg, Kristina Gislén, et al.Journal of Medicinal Chemistry|September 22, 2009
Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluidsMarkus Fridén, Susanne Winiwarter, Gunilla Jerndal, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 14, 2003
Absorption, distribution, metabolism, and excretion of ximelagatran, an oral direct thrombin inhibitor, in rats, dogs, and humansUlf G Eriksson, Ulf Bredberg, Kurt-Jürgen Hoffmann, et al.Drug Discovery Today|June 4, 2013
Model-based drug discovery: implementation and impactSandra A G Visser, Malin Aurell, Rhys D O Jones, et al.Pageof 2